Non-genomic effects of PPARγ ligands: inhibition of GPVI-stimulated platelet activation

Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs

(2009) Ferhana Y. Ali et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

NF-κB inhibitors impair platelet activation responses

(2009) E. MALAVER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A dual role for integrin-linked kinase in platelets: regulating integrin function and  -granule secretion

(2008) K. L. Tucker et al.   BLOOD

Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation

(2007) M.P. Khanolkar et al.   ATHEROSCLEROSIS

Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation

(2007) S. Jones et al.   BLOOD

Platelet Sarcoplasmic Endoplasmic Reticulum Ca 2+ -ATPase and μ-Calpain Activity Are Altered in Type 2 Diabetes Mellitus and Restored by Rosiglitazone

(2007) Voahanginirina Randriamboavonjy et al.   CIRCULATION